Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Revolution Medicines (RVMD) Other Non Operating Income (2024 - 2025)

Revolution Medicines (RVMD) has 2 years of Other Non Operating Income data on record, last reported at $1.3 million in Q4 2025.

  • For Q4 2025, Other Non Operating Income changed N/A year-over-year to $1.3 million; the TTM value through Dec 2025 reached $1.3 million, changed N/A, while the annual FY2025 figure was $1.3 million, N/A changed from the prior year.
  • Other Non Operating Income reached $1.3 million in Q4 2025 per RVMD's latest filing, up from -$10000.0 in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $1.3 million in Q4 2025 and bottomed at -$10000.0 in Q1 2025.